Actively Recruiting
Normal Reference Range for Neonatal Echocardiography
Led by Children's Hospital of Chongqing Medical University · Updated on 2024-07-16
1500
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
Sponsors
C
Children's Hospital of Chongqing Medical University
Lead Sponsor
S
Shanxi Provincial Maternity and Children's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Echocardiography is the main method of bedside examination of neonatal cardiac morphology, which can timely diagnose congenital heart disease and quantitatively assess its severity, but the diagnosis and evaluation process depends on the normal range of neonatal echocardiography.At present, there have been normal reference standards for echocardiography in children and adults at home and abroad, but there is no uniform standard for echocardiographic parameters in newborns, especially premature infants.This study intends to carry out a national multicenter, prospective, observational study to establish the reference range of echocardiography at different time periods after birth in newborns, and stratified according to gestational age, birth weight and gender, to conduct a more accurate hemodynamic assessment of clinically critically ill newborns and guide the treatment of critically ill newborns in real time.
CONDITIONS
Official Title
Normal Reference Range for Neonatal Echocardiography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Outpatient or inpatient neonate
- Gestational age > 30 weeks and birthweight > 1250 grams
- Appropriate for gestational age
- Without perinatal asphyxia
- Without skin lesion on the left chest wall
- Family informed consent for neonatal echocardiography
You will not qualify if you...
- Specialist cardiac ultrasound suggests congenital heart disease
- PDA with hemodynamic abnormalities (PDA > 1.5 mm left-to-right shunt and left atrial diameter/aortic root > 1.5 or need for inotropes)
- Invasive mechanical ventilation therapy
- Non-invasive mechanical ventilation with FiO2 > 0.3
- Major anomalies
- Blood culture-proven neonatal sepsis
- Persistent pulmonary hypertension
- Renal failure
- Necrotizing enterocolitis ≥ stage II
- Post surgery
- Maternal history of severe anemia or prenatal massive bleeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400014
Actively Recruiting
Research Team
W
Wang Jianhui, Doctor
CONTACT
D
Dong Wenhui, Master
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here